CDK1 and hepatocellular carcinoma: Furthermore, Zhu et al. found that CDK1 overexpression was a prognostic factor for hepatocellular carcinoma (HCC), which makes it a potential therapeutic target and biomarker for HCC diagnosis, through analysis data from GEO and the Cancer Genome Atlas (TCGA)5.